Article
JAK-STAT Pathway Heterogeneity Governs Immunotherapy Response in Breast Cancer
2026-02-05
Abstract excerpt
The JAK-STAT pathway (JSP) is a well-known oncogenic cascade; however, recent clinical trials have detected JSP upregulation in breast cancer following anti-PD1 immunotherapy. This paradoxical observation warrants further investigation into JSP’s intercellular heterogeneity, tumor dynamics, molecular mechanisms, and clinical implications for immunotherapy. JSP expression showed dynamic shifts during breast cancer...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 7a0cfffd-e2fc-581a-a273-86c5665115d7
- DOI
- 10.64898/2026.02.03.703506
